<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00502255</url>
  </required_header>
  <id_info>
    <org_study_id>072036</org_study_id>
    <nct_id>NCT00502255</nct_id>
  </id_info>
  <brief_title>Telemonitoring in Patients With Heart Failure</brief_title>
  <acronym>TEHAF2</acronym>
  <official_title>Telemonitoring in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if telemonitoring results in a decrease in
      hospital admissions, with equal quality of care defined as mortality, quality of life and
      unplanned visits with caregivers. Telemonitoring is expected to be more cost-effective than
      usual care in patients with heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To what extent does the use of Health Buddy result in a decrease in hospital admissions?</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To what extent is Health Buddy® more cost-effective than usual care?</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To what extent will the amount of planned contacts decrease without an increase of unplanned contacts?</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>What is the effect of Health Buddy® in patients with heart failure in regard to drug consumption and therapy compliance and level of knowledge, and quality of life?</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To what extent is it - based on patients' characteristics - possible to identify patient with benefits?</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">382</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <arm_group>
    <arm_group_label>telemonitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Health Buddy in patients home situation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receive care as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Health Buddy system</intervention_name>
    <description>Patients are followed on distance by the Health Buddy system.</description>
    <arm_group_label>telemonitoring</arm_group_label>
    <other_name>TEHAF study</other_name>
    <other_name>Therapy compliance in patients with heart failure</other_name>
    <other_name>Cost effectiveness</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemonitoring in patients with heart failure</intervention_name>
    <description>Health Buddy in patients home situation.</description>
    <arm_group_label>usual care</arm_group_label>
    <other_name>TEHAf study</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years

          -  Patients with heart failure NYHA classification II-III-IV

          -  Patient experienced a period of fluid retention

          -  Patient is treated by a cardiologist

          -  Patient is followed-up by a heart failure nurse

          -  Adequate knowledge of the Dutch language

          -  Patient has an active telephone connection, preferably analogue

          -  Patient is mental competent

          -  Patient has the disposal of a balance

        Exclusion Criteria:

          -  Patients suffering from COPD, Gold classification 3 or 4

          -  Patient is a dialysis patient

          -  Patient has a visual restriction to read the dialogues on the Health Buddy

          -  Patient is hard of hearing or deaf

          -  Patient suffers from a lethal sickness with a prognosis &lt; 1 year

          -  Patient participates in another trial

          -  Patient needs a hospital admission on short time, i.e., &lt; 3 months

          -  Patient used the Health Buddy in an earlier stage

          -  Patient is an illiterate person.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hubertus J Vrijhoef, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>University Maastricht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Atrium Medische Centrum</name>
      <address>
        <city>Heerlen</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Hospital</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orbis Medische en Zorgconcern</name>
      <address>
        <city>Sittard</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2007</study_first_submitted>
  <study_first_submitted_qc>July 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2007</study_first_posted>
  <last_update_submitted>April 7, 2015</last_update_submitted>
  <last_update_submitted_qc>April 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Josiane Boyne</investigator_full_name>
    <investigator_title>RN,MA</investigator_title>
  </responsible_party>
  <keyword>Telemonitoring</keyword>
  <keyword>Cost-effectiveness</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Case management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

